Last 12 months
Inside the activity.
11 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 2 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 3 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 02, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 6 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 18,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · derivative · entry 10 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,950 Underlying: Common Stock, par value $0.0001 · 18,950 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F7 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F7 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 8,282 | $6.64 | $54,992.48 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 7 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 355,082 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionCommon Stock, par value $0.0001 | 18,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 6 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,364 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · derivative · entry 10 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,775 Underlying: Common Stock, par value $0.0001 · 7,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F7 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date F7 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 2,316 | $6.64 | $15,378.24 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 7 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,220 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| February 02, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 7,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 6 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,536 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · derivative · entry 9 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.0001 · 6,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F6 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 2,109 | $6.64 | $14,003.76 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 5 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,789 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 4 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 16,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · derivative · entry 9 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.0001 · 16,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F6 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 7,231 | $6.64 | $48,013.84 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 5 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 344,414 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionCommon Stock, par value $0.0001 | 16,545 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 4 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · derivative · entry 9 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.0001 · 6,166 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F6 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F6 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following February 1, 2021, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 1,801 | $6.64 | $11,958.64 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 5 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,761 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 6,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 4 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
GrantCommon Stock, par value $0.0001 | 1,905 | $5.18 | $9,867.90 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 3 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,732 F3 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025. F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
GrantCommon Stock, par value $0.0001 | 4,105 | $5.18 | $21,263.90 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 3 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,100 F3 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025. F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:45 UTC |
Jordt Raymond MChief Business Officer
|
GrantCommon Stock, par value $0.0001 | 2,614 | $5.18 | $13,540.52 |
DisclosureSEC source: 0001104659-25-008771 · tm255357-2_4seq1.xml · nonDerivative · entry 1 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,902 F1 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on August 1, 2024. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
GrantCommon Stock, par value $0.0001 | 3,184 | $5.18 | $16,493.12 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 3 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,396 F3 · kind: These shares were purchased due to participation by the reporting individual in the Issuer's 2019 Employee Stock Purchase Plan ("ESPP"). It pertains to the ESPP purchase period from August 1, 2024 through January 31, 2025. F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 1, 2024. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · derivative · entry 8 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,550 Underlying: Common Stock, par value $0.0001 · 9,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 3,173 | $7.00 | $22,211.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 2 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,827 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:48 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008772 · tm255357-3_4seq1.xml · nonDerivative · entry 1 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 26,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · derivative · entry 8 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,550 Underlying: Common Stock, par value $0.0001 · 26,775 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 11,701 | $7.00 | $81,907.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 2 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,995 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:50 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionCommon Stock, par value $0.0001 | 26,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008773 · tm255357-4_4seq1.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342,696 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · derivative · entry 8 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,550 Underlying: Common Stock, par value $0.0001 · 9,275 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 30, 2023, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 2,709 | $7.00 | $18,963.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 2 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,212 F1 · kind: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 30, 2025 Filed Feb 4, 2025 01:43 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 9,275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-008770 · tm255357-1_4seq1.xml · nonDerivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,921 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:06 UTC |
Roberts M ScotChief Scientific Officer
|
GrantRestricted Stock Units · Derivative | 63,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006845 · tm254755-4_4seq1.xml · derivative · entry 6 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,400 Underlying: Common Stock, par value $0.0001 · 63,400 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:06 UTC |
Roberts M ScotChief Scientific Officer
|
GrantStock Options (option to buy) · Derivative | 183,600 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006845 · tm254755-4_4seq1.xml · derivative · entry 5 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,600 Underlying: Common Stock, par value $0.0001 · 183,600 shares Expires 2035-01-27 F4 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:05 UTC |
Jordt Raymond MChief Business Officer
|
GrantRestricted Stock Units · Derivative | 63,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006843 · tm254755-3_4seq1.xml · derivative · entry 5 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,400 Underlying: Common Stock, par value $0.0001 · 63,400 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:05 UTC |
Jordt Raymond MChief Business Officer
|
GrantStock Options (option to buy) · Derivative | 183,600 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006843 · tm254755-3_4seq1.xml · derivative · entry 4 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,600 Underlying: Common Stock, par value $0.0001 · 183,600 shares Expires 2035-01-27 F4 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:05 UTC |
Harris Matthew ScottChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 63,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006841 · tm254755-2_4seq1.xml · derivative · entry 5 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,400 Underlying: Common Stock, par value $0.0001 · 63,400 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:05 UTC |
Harris Matthew ScottChief Medical Officer
|
GrantStock Options (option to buy) · Derivative | 183,600 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006841 · tm254755-2_4seq1.xml · derivative · entry 4 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,600 Underlying: Common Stock, par value $0.0001 · 183,600 shares Expires 2035-01-27 F4 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:04 UTC |
Garg Vipin KDirector · President and CEO
|
GrantRestricted Stock Units · Derivative | 164,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006837 · tm254755-1_4seq1.xml · derivative · entry 5 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,800 Underlying: Common Stock, par value $0.0001 · 164,800 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F5 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F5 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 27, 2025, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 02:04 UTC |
Garg Vipin KDirector · President and CEO
|
GrantStock Options (option to buy) · Derivative | 477,500 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006837 · tm254755-1_4seq1.xml · derivative · entry 4 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 477,500 Underlying: Common Stock, par value $0.0001 · 477,500 shares Expires 2035-01-27 F4 · derivative.exercise_date: Twenty-five percent of the shares underlying the option become vested and released on January 27, 2026 and the remaining 75% of the shares underlying the option become vested and released in substantially equal monthly installments over the 36 months following January 27, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:06 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006845 · tm254755-4_4seq1.xml · derivative · entry 4 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,800 Underlying: Common Stock, par value $0.0001 · 14,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:06 UTC |
Roberts M ScotChief Scientific Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 4,264 | $6.98 | $29,762.72 |
DisclosureSEC source: 0001104659-25-006845 · tm254755-4_4seq1.xml · nonDerivative · entry 2 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,646 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:06 UTC |
Roberts M ScotChief Scientific Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006845 · tm254755-4_4seq1.xml · nonDerivative · entry 1 Roberts M Scot · CIK 0001705905 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,910 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Jordt Raymond MChief Business Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006843 · tm254755-3_4seq1.xml · derivative · entry 3 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,800 Underlying: Common Stock, par value $0.0001 · 14,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Jordt Raymond MChief Business Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 3,862 | $6.98 | $26,956.76 |
DisclosureSEC source: 0001104659-25-006843 · tm254755-3_4seq1.xml · nonDerivative · entry 2 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,288 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Jordt Raymond MChief Business Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006843 · tm254755-3_4seq1.xml · nonDerivative · entry 1 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006841 · tm254755-2_4seq1.xml · derivative · entry 3 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,800 Underlying: Common Stock, par value $0.0001 · 14,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Harris Matthew ScottChief Medical Officer
|
Tax withholdingCommon Stock, par value $0.0001 | 4,994 | $6.98 | $34,858.12 |
DisclosureSEC source: 0001104659-25-006841 · tm254755-2_4seq1.xml · nonDerivative · entry 2 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,725 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:05 UTC |
Harris Matthew ScottChief Medical Officer
|
Exercise / conversionCommon Stock, par value $0.0001 | 14,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006841 · tm254755-2_4seq1.xml · nonDerivative · entry 1 Harris Matthew Scott · CIK 0001787762 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:04 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 42,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006837 · tm254755-1_4seq1.xml · derivative · entry 3 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,150 Underlying: Common Stock, par value $0.0001 · 42,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs vest in substantially equal annual installments over the 4 years following January 25, 2024, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:04 UTC |
Garg Vipin KDirector · President and CEO
|
Tax withholdingCommon Stock, par value $0.0001 | 18,157 | $6.98 | $126,735.86 |
DisclosureSEC source: 0001104659-25-006837 · tm254755-1_4seq1.xml · nonDerivative · entry 2 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,921 F2 · kind: Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of RSUs. Read SEC document |
| January 25, 2025 Filed Jan 29, 2025 02:04 UTC |
Garg Vipin KDirector · President and CEO
|
Exercise / conversionCommon Stock, par value $0.0001 | 42,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-006837 · tm254755-1_4seq1.xml · nonDerivative · entry 1 Garg Vipin K · CIK 0001515813 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,078 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:40 UTC |
Jordt Raymond MChief Business Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000836 · tm251877-1_4seq1.xml · derivative · entry 3 Jordt Raymond M · CIK 0001960780 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock, par value $0.0001 · 9,375 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. F3 · derivative.exercise_date: The RSUs become vested and released over four (4) years with 25% of the shares vesting on January 1, 2024, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. F3 · derivative.expiration_date: The RSUs become vested and released over four (4) years with 25% of the shares vesting on January 1, 2024, with the remainder vesting in equal annual installments for the following three (3) years, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.